ReviewJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022
Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma.
Ingo K Mellinghoff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it